Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 7/20 | 0.48 |
| ▸ | CREBBP | Q92793 | 7/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | RHOC | P08134 | 1/20 | 0.40 |
| ▸ | RHOA | P61586 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872883 | 0.91 | DPP4 (0.42) | EP300CREBBPDPP4 | |
| SCHEMBL844929 | 0.83 | EP300 (0.53) | EP300CREBBPCYP2C9CYP2C19HTT | |
| SCHEMBL844920 | 0.81 | EP300 (0.48) | EP300CREBBPCYP2C9CYP2C19HTT | |
| SCHEMBL14648118 | 0.78 | EP300 (0.41) | EP300CREBBPCYP2C9CYP2C19NPC1 | |
| SCHEMBL844884 | 0.77 | HTT (0.48) | EP300CREBBPCYP2C9CYP2C19HTT | |
| SCHEMBL845170 | 0.76 | CYP2C9 (0.47) | EP300CREBBPCYP2C9CYP2C19HTT | |
| SCHEMBL845255 | 0.76 | CYP2C9 (0.47) | CYP2C9CYP2C19HTTNPC1ALDH1A1 | |
| SCHEMBL845258 | 0.76 | MAPK1 (0.60) | EP300CREBBPCYP2C9CYP2C19HTT | |
| SCHEMBL873200 | 0.75 | RHOC (0.48) | CYP2C9CYP2C19HTTNPC1ALDH1A1 | |
| SCHEMBL844890 | 0.75 | KCNH2 (0.51) | CYP2C9CYP2C19HTTNPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |